Finance

Lists
Why is 4TZ up 2,94%?
Dive Deeper
4TZ:FRA
ORIC Pharmaceuticals Inc
10,50 €
+2,94%
(+0,30) 1D
9 ოქტ, 15:47:18 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 4TZ...
Open
10,54 €
High
10,54 €
Low
10,50 €
Mkt. cap
1,27 მლრდ.
Avg. vol.
0,00
Volume
0,00
52-wk high
12,32 €
52-wk low
6,10 €
No. of employees
111
Open
10,54 €
High
10,54 €
Low
10,50 €
Mkt. cap
1,27 მლრდ.
Avg. vol.
0,00
Volume
0,00
52-wk high
12,32 €
52-wk low
6,10 €
No. of employees
111
News stories
From web sources and news partners
About ORIC Pharmaceuticals Inc
CEO-
Employees111
Founded2014
HeadquartersSouth San Francisco, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
28,77 მლნ.
25,86 მლნ.
31,44 მლნ.
36,30 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,90 მლნ.
8,70 მლნ.
8,18 მლნ.
9,00 მლნ.
Operating expense
36,67 მლნ.
34,55 მლნ.
39,62 მლნ.
45,30 მლნ.
Total operating expenses
36,67 მლნ.
34,55 მლნ.
39,62 მლნ.
45,30 მლნ.
Operating income
-36,67 მლნ.
-34,55 მლნ.
-39,62 მლნ.
-45,30 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-32,59 მლნ.
-30,50 მლნ.
-35,77 მლნ.
-41,49 მლნ.
EBT excluding unusual items
-32,59 მლნ.
-30,50 მლნ.
-35,77 მლნ.
-41,49 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-32,59 მლნ.
-30,50 მლნ.
-35,77 მლნ.
-41,49 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,33
-0,30
-0,34
-0,38
Interest and investment income
4,08 მლნ.
4,05 მლნ.
3,85 მლნ.
3,80 მლნ.
Interest expense
-
-
-
-
Net interest expenses
4,08 მლნ.
4,05 მლნ.
3,85 მლნ.
3,80 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-36,38 მლნ.
-34,23 მლნ.
-39,35 მლნ.
-45,03 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები